curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH

by palligoelme@gmail.com | Jun 2, 2025 | Clinical Trials

​ Conditions: Heterozygous Familial Hypercholesterolaemia Interventions: Drug: AZD0780; Drug: Placebo Sponsors: AstraZeneca Not yet recruiting Conditions: Heterozygous Familial Hypercholesterolaemia Interventions: Drug: AZD0780; Drug: Placebo Sponsors: AstraZeneca Not...

Communicating Uncertainties Associated With the Benefits and Risks of New Cancer Drugs

by palligoelme@gmail.com | May 30, 2025 | Clinical Trials

​ Conditions: Cancer Interventions: Other: Statement communicating uncertainty with a single arm trial; Other: Statement communicating uncertainty with limited study duration; Other: Statement communicating uncertainty with a limited study population; Other: Statement...

J-Tip Use for Paracentesis in Adults With Liver Cirrhosis and Ascites

by palligoelme@gmail.com | May 30, 2025 | Clinical Trials

​ Conditions: Evaluate Patient Comfort Level During Paracentesis by Numbing Skin With a Needle-less Device, Instead of Using a Needle to Numb the Skin Interventions: Device: Experimental J-Tip Needle-Free Injection System; Device: Control (Standard treatment)...

The Relationship Between Cervical Endurance Time and Eye Gaze

by palligoelme@gmail.com | May 30, 2025 | Clinical Trials

​ Conditions: Endurance Time During Gazing Interventions: Other: – Cervical Vestibular-Evoked Myogenic Potential (cVEMP) along the Sternocleidomastoid Sponsors: Al-Ahliyya Amman University Not yet recruiting Conditions: Endurance Time During Gazing...

A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.

by palligoelme@gmail.com | May 30, 2025 | Clinical Trials

​ Conditions: Healthy Interventions: Drug: AZD1613; Drug: Placebo Sponsors: AstraZeneca; Parexel Not yet recruiting Conditions: Healthy Interventions: Drug: AZD1613; Drug: Placebo Sponsors: AstraZeneca; Parexel Not yet...

Analysis of Factors Associated With The Occurrence of Amniotic Fluid Entry in Patients Undergoing Caesarean Section

by palligoelme@gmail.com | May 28, 2025 | Clinical Trials

​ Conditions: Amniotic Fluid Embolism Interventions: Diagnostic Test: Enzyme-linked immunosorbent assay Sponsors: Second Hospital of Shanxi Medical University Not yet recruiting Conditions: Amniotic Fluid Embolism Interventions: Diagnostic Test: Enzyme-linked...
« Older Entries
Next Entries »

Recent Posts

  • Multi-center Prospective Validation of Real-Time AI-EGGIM System
  • Bacterial Reduction in Apical Root Canals After Bioceramic or Calcium Hydroxide Medicament
  • SELF-ASSESSMENT AND KNOWLEDGE LEVEL OF NURSING STUDENTS’ PATIENT SAFETY COMPETENCY
  • A Phase Ib/II Study of GFH276 in Combination With Chemotherapy (± Bevacizumab) or Cetuximab in Patients With RAS-mutant Metastatic Colorectal Cancer
  • Platelet Transfusion Thresholds in Non-Bleeding Patients

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®